Loxo Oncology (LOXO) Reports Q3 Loss of $0.82/Share

November 2, 2016 6:46 AM EDT
Get Alerts LOXO Hot Sheet
Trade LOXO Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Loxo Oncology (NASDAQ: LOXO) reported Q3 EPS of ($0.82), versus ($0.53) reported last year.

For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment